Kappac Pharma Ltd. - Research Center
506938 KAPPH Group (XC) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | |
|---|---|---|---|---|---|
| Sales | - | - | 1.00 | - | - |
| Operating profit | -0.03 | -0.02 | -0.05 | -0.01 | -0.04 |
| Interest | - | - | - | - | - |
| Gross profit | -2.20 | -0.02 | -0.05 | -0.01 | -0.04 |
| EPS (Rs) | -0.73 | -0.01 | -0.02 | - | -0.01 |
Annual
results in details
| Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | |
|---|---|---|---|---|---|
| Other income | -2.17 | - | - | - | - |
| Stock adjustment | - | - | - | - | - |
| Raw material | - | - | - | - | - |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.01 | 0.01 | - | - | - |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 0.01 | - | 1.05 | 0.01 | 0.04 |
| Provisions made | - | - | - | - | - |
| Depreciation | - | - | - | - | - |
| Taxation | - | - | - | - | - |
| Net profit / loss | -2.20 | -0.02 | -0.05 | -0.01 | -0.04 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 30.27 | 30.27 | 30.27 | 30.27 | 30.27 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | - | - | -4.97 | - | - |
| GPM (%) | - | - | - | - | - |
| NPM (%) | - | - | - | - | - |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis